dalteparin has been researched along with Encephalopathy, Hepatic in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lv, Y | 1 |
| Bai, W | 1 |
| Li, K | 1 |
| Wang, Z | 1 |
| Guo, W | 1 |
| Luo, B | 1 |
| Wang, J | 1 |
| Wang, Q | 1 |
| Wang, E | 1 |
| Xia, D | 1 |
| Li, X | 1 |
| Yuan, J | 1 |
| Han, N | 1 |
| Niu, J | 1 |
| Yin, Z | 1 |
| Fan, D | 1 |
| Han, G | 1 |
1 other study available for dalteparin and Encephalopathy, Hepatic
| Article | Year |
|---|---|
Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
Topics: Adult; Aged; Algorithms; Anticoagulants; Combined Modality Therapy; Enoxaparin; Female; Hemorrhage; | 2021 |